By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kala Pharmaceuticals 

135 Beaver Street
Suite 309
Waltham  Massachusetts  02452  U.S.A.
Phone: 781-996-5252 Fax: 781-642-0399



Company News
Kala Pharma Announces Positive Results From Confirmatory Phase III Trial Of KPI-121 1% Following Cataract Surgery 5/1/2017 7:51:38 AM
Massachusetts' Mucus Penetrating Eye Disease Firm Kala Pharma Raises $68 Million 4/13/2016 6:17:16 AM
Kala Pharmaceuticals Appoints Mark Iwicki As Executive Chairman 5/14/2015 12:33:53 PM
Kala Pharmaceuticals KPI-121 Meets Primary Sign Endpoint In Phase II For Dry Eye Disease 4/1/2015 11:40:10 AM
Kala Pharmaceuticals KPI-121 Meets All Primary Endpoints In Phase III For Cataract Surgery 4/1/2015 11:36:10 AM
Kala Pharmaceuticals Initiates Phase 2 Clinical Trial To Evaluate LE-MPP (KPI-121) In Patients With Retinal Vein Occlusion And Diabetic Macular Edema 7/31/2014 10:57:28 AM
Kala Pharmaceuticals Initiates Phase 3 Clinical Trial for Treatment of Post Surgical Ocular Inflammation and Phase 2 Clinical Trial in Dry Eye 6/19/2014 11:13:11 AM
Massachusetts' Kala Pharmaceuticals Nabs $22.5 Million More For Eye Drugs 4/23/2014 6:28:23 AM
Kala Pharmaceuticals Announces IND Submission Of Its MPP-Formulated Loteprednol Etonbonate (LE-MPP) For Post-Cataract Surgery 1/6/2014 8:19:09 AM
Kala Pharmaceuticals Appoints Howard B. Rosen As Chairman Of The Board Of Directors 1/6/2014 6:40:23 AM